|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Table 3: Prevalence (%) of the outcome variables increased HbA1c, elevated triglycerides, elevated total cholesterol, and hypertension (systolic/diastolic) in Assyrian/Syrian and Swedish patients with type 2 diabetes by ethnicity and sex and test of differences in distribution by ethnicity (Pr-value). |